The incidence of HMCN1 variants in the AMD patients with PED was too low and the tested group was too small to test for significance; however, it might be of relevance to distinguish between AMD-only patients and those prone to PED development, and this should be investigated in a larger group of patients. Here, HMCN1 is linked to age-related macular degeneration.